Drugs / intravenous immunoglobulin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02298062 Comparator | Jan 2013 → Jul 2015 | Kawasaki disease | Fudan University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | intravenous immunoglobulin | “first dose of intravenous immunoglobulin (IVIG) (2g/kg)” NCT02298062 ↗ |
| Known as | IVIG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02298062 ↗ |
| Modality | Protein / enzyme biologic | “intravenous immunoglobulin” NCT02298062 ↗ |
| Route | Intravenous | “first dose of intravenous immunoglobulin (IVIG) (2g/kg)” NCT02298062 ↗ |